HEADER HYDROLASE 22-JUL-10 3O2R TITLE STRUCTURAL FLEXIBILITY IN REGION INVOLVED IN DIMER FORMATION OF TITLE 2 NUCLEASE DOMAIN OF RIBONUCLASE III (RNC) FROM CAMPYLOBACTER JEJUNI COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBONUCLEASE III; COMPND 3 CHAIN: A, C; COMPND 4 EC: 3.1.26.3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: RIBONUCLEASE III; COMPND 8 CHAIN: B, D; COMPND 9 EC: 3.1.26.3; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI SUBSP. JEJUNI; SOURCE 3 ORGANISM_TAXID: 192222; SOURCE 4 STRAIN: NCTC 11168; SOURCE 5 GENE: CJSA_1547, RNC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-DE3 (MAGIC); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI SUBSP. JEJUNI; SOURCE 13 ORGANISM_TAXID: 192222; SOURCE 14 STRAIN: NCTC 11168; SOURCE 15 GENE: CJSA_1547, RNC; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21-DE3 (MAGIC); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PMCSG7 KEYWDS STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS KEYWDS 2 DISEASES, CSGID, NUCLEASE DOMAIN, RIBONUCLASE III, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.MINASOV,A.HALAVATY,L.SHUVALOVA,I.DUBROVSKA,J.WINSOR,L.PAPAZISI, AUTHOR 2 W.F.ANDERSON,CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES AUTHOR 3 (CSGID) REVDAT 4 06-SEP-23 3O2R 1 REMARK SEQADV LINK REVDAT 3 08-NOV-17 3O2R 1 REMARK REVDAT 2 30-MAY-12 3O2R 1 SEQADV VERSN REVDAT 1 04-AUG-10 3O2R 0 JRNL AUTH G.MINASOV,A.HALAVATY,L.SHUVALOVA,I.DUBROVSKA,J.WINSOR, JRNL AUTH 2 L.PAPAZISI,W.F.ANDERSON, JRNL AUTH 3 CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES JRNL AUTH 4 (CSGID) JRNL TITL STRUCTURAL FLEXIBILITY IN REGION INVOLVED IN DIMER FORMATION JRNL TITL 2 OF NUCLEASE DOMAIN OF RIBONUCLASE III (RNC) FROM JRNL TITL 3 CAMPYLOBACTER JEJUNI. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 143537 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.135 REMARK 3 R VALUE (WORKING SET) : 0.133 REMARK 3 FREE R VALUE : 0.168 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7589 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 10625 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.55 REMARK 3 BIN R VALUE (WORKING SET) : 0.1850 REMARK 3 BIN FREE R VALUE SET COUNT : 546 REMARK 3 BIN FREE R VALUE : 0.2140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4558 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 973 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.13000 REMARK 3 B22 (A**2) : -0.78000 REMARK 3 B33 (A**2) : 0.65000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.05000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.045 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.045 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.018 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.866 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.977 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.966 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5414 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3703 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7382 ; 1.287 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9191 ; 0.891 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 725 ; 4.041 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 255 ;38.380 ;25.843 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1046 ;11.452 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;12.021 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 814 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6304 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1082 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3316 ; 1.551 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1329 ; 1.933 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5394 ; 2.300 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2098 ; 3.536 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1973 ; 5.145 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5414 ; 1.716 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3O2R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1000060591. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97856 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : BERYLLIUM LENSES REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 151202 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.35900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3N3W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 7.6 MG/ML, 0.5M REMARK 280 SODIUM CHLORIDE, 0.01M TRIS PH 8.3; SCREEN SOLUTION: PACT (B1), REMARK 280 0.1M MIB BUFFER PH 4.0, 25% W/V PEG1500, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.77600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 SER A -16 REMARK 465 SER A -15 REMARK 465 GLY A -14 REMARK 465 VAL A -13 REMARK 465 ASP A -12 REMARK 465 LEU A -11 REMARK 465 GLY A -10 REMARK 465 THR A -9 REMARK 465 GLU A -8 REMARK 465 ASN A -7 REMARK 465 LEU A -6 REMARK 465 TYR A -5 REMARK 465 PHE A -4 REMARK 465 GLN A -3 REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 MET B -23 REMARK 465 HIS B -22 REMARK 465 HIS B -21 REMARK 465 HIS B -20 REMARK 465 HIS B -19 REMARK 465 HIS B -18 REMARK 465 HIS B -17 REMARK 465 SER B -16 REMARK 465 SER B -15 REMARK 465 GLY B -14 REMARK 465 VAL B -13 REMARK 465 ASP B -12 REMARK 465 LEU B -11 REMARK 465 GLY B -10 REMARK 465 THR B -9 REMARK 465 GLU B -8 REMARK 465 ASN B -7 REMARK 465 LEU B -6 REMARK 465 TYR B -5 REMARK 465 PHE B -4 REMARK 465 GLN B -3 REMARK 465 SER B -2 REMARK 465 ASN B -1 REMARK 465 ALA B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 GLN B 145 REMARK 465 MET C -23 REMARK 465 HIS C -22 REMARK 465 HIS C -21 REMARK 465 HIS C -20 REMARK 465 HIS C -19 REMARK 465 HIS C -18 REMARK 465 HIS C -17 REMARK 465 SER C -16 REMARK 465 SER C -15 REMARK 465 GLY C -14 REMARK 465 VAL C -13 REMARK 465 ASP C -12 REMARK 465 LEU C -11 REMARK 465 GLY C -10 REMARK 465 THR C -9 REMARK 465 GLU C -8 REMARK 465 ASN C -7 REMARK 465 LEU C -6 REMARK 465 TYR C -5 REMARK 465 PHE C -4 REMARK 465 GLN C -3 REMARK 465 SER C -2 REMARK 465 ASN C -1 REMARK 465 ALA C 0 REMARK 465 MET C 1 REMARK 465 LYS C 2 REMARK 465 MET D -23 REMARK 465 HIS D -22 REMARK 465 HIS D -21 REMARK 465 HIS D -20 REMARK 465 HIS D -19 REMARK 465 HIS D -18 REMARK 465 HIS D -17 REMARK 465 SER D -16 REMARK 465 SER D -15 REMARK 465 GLY D -14 REMARK 465 VAL D -13 REMARK 465 ASP D -12 REMARK 465 LEU D -11 REMARK 465 GLY D -10 REMARK 465 THR D -9 REMARK 465 GLU D -8 REMARK 465 ASN D -7 REMARK 465 LEU D -6 REMARK 465 TYR D -5 REMARK 465 PHE D -4 REMARK 465 GLN D -3 REMARK 465 SER D -2 REMARK 465 ASN D -1 REMARK 465 ALA D 0 REMARK 465 MET D 1 REMARK 465 LYS D 2 REMARK 465 GLN D 145 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 33 19.56 58.27 REMARK 500 PHE C 143 45.34 -164.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 225 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 225 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 225 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 225 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3N3W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NUCLEASE DOMAIN OF RIBONUCLASE III (RNC) FROM REMARK 900 CAMPYLOBACTER JEJUNI. REMARK 900 RELATED ID: IDP90862 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN CHAINS B AND D, RESIDUE 31 DISPLAYS MICROHETEROGENEITY AND REMARK 999 APPEARS AS BOTH A METHYLATED LYSINE AND LYSINE. THE ORIGINAL REMARK 999 SEQUENCE WAS THE 224 RESIDUES AS FOUND IN THE UNIPROT ENTRY - BUT REMARK 999 THE AUTHORS SEE A CLEAR TRUNCATION AT 164. DBREF 3O2R A 1 146 UNP D3FPA5 D3FPA5_CAMJI 1 146 DBREF 3O2R B 1 146 UNP D3FPA5 D3FPA5_CAMJI 1 146 DBREF 3O2R C 1 146 UNP D3FPA5 D3FPA5_CAMJI 1 146 DBREF 3O2R D 1 146 UNP D3FPA5 D3FPA5_CAMJI 1 146 SEQADV 3O2R MET A -23 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS A -22 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS A -21 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS A -20 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS A -19 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS A -18 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS A -17 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER A -16 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER A -15 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY A -14 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R VAL A -13 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASP A -12 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU A -11 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY A -10 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R THR A -9 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLU A -8 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN A -7 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU A -6 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R TYR A -5 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R PHE A -4 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLN A -3 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER A -2 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN A -1 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ALA A 0 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R MET B -23 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS B -22 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS B -21 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS B -20 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS B -19 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS B -18 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS B -17 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER B -16 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER B -15 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY B -14 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R VAL B -13 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASP B -12 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU B -11 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY B -10 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R THR B -9 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLU B -8 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN B -7 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU B -6 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R TYR B -5 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R PHE B -4 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLN B -3 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER B -2 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN B -1 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ALA B 0 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R MLZ B 31 UNP D3FPA5 LYS 31 MICROHETEROGENEITY SEQADV 3O2R MET C -23 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS C -22 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS C -21 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS C -20 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS C -19 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS C -18 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS C -17 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER C -16 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER C -15 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY C -14 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R VAL C -13 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASP C -12 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU C -11 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY C -10 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R THR C -9 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLU C -8 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN C -7 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU C -6 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R TYR C -5 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R PHE C -4 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLN C -3 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER C -2 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN C -1 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ALA C 0 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R MET D -23 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS D -22 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS D -21 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS D -20 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS D -19 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS D -18 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R HIS D -17 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER D -16 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER D -15 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY D -14 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R VAL D -13 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASP D -12 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU D -11 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLY D -10 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R THR D -9 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLU D -8 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN D -7 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R LEU D -6 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R TYR D -5 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R PHE D -4 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R GLN D -3 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R SER D -2 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ASN D -1 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R ALA D 0 UNP D3FPA5 EXPRESSION TAG SEQADV 3O2R MLZ D 31 UNP D3FPA5 LYS 31 MICROHETEROGENEITY SEQRES 1 A 170 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 170 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA MET LYS SEQRES 3 A 170 ASN ILE GLU LYS LEU GLU GLN SER LEU THR TYR GLU PHE SEQRES 4 A 170 LYS ASP LYS ASN LEU LEU ILE HIS ALA LEU THR HIS LYS SEQRES 5 A 170 SER PHE LYS LYS SER TYR ASN ASN GLU ARG LEU GLU PHE SEQRES 6 A 170 LEU GLY ASP ALA VAL LEU ASP LEU VAL VAL GLY GLU TYR SEQRES 7 A 170 LEU PHE HIS LYS PHE ALA LYS ASP ALA GLU GLY ASP LEU SEQRES 8 A 170 SER LYS LEU ARG ALA ALA LEU VAL ASN GLU LYS SER PHE SEQRES 9 A 170 ALA LYS ILE ALA ASN SER LEU ASN LEU GLY ASP PHE ILE SEQRES 10 A 170 LEU MET SER VAL ALA GLU GLU ASN ASN GLY GLY LYS GLU SEQRES 11 A 170 LYS PRO SER ILE LEU SER ASP ALA LEU GLU ALA ILE ILE SEQRES 12 A 170 GLY ALA ILE HIS LEU GLU ALA GLY PHE GLU PHE ALA LYS SEQRES 13 A 170 THR ILE ALA LEU ARG LEU ILE GLU LYS ASN PHE PRO GLN SEQRES 14 A 170 ILE SEQRES 1 B 170 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 170 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA MET LYS SEQRES 3 B 170 ASN ILE GLU LYS LEU GLU GLN SER LEU THR TYR GLU PHE SEQRES 4 B 170 LYS ASP LYS ASN LEU LEU ILE HIS ALA LEU THR HIS LYS SEQRES 5 B 170 SER PHE MLZ LYS SER TYR ASN ASN GLU ARG LEU GLU PHE SEQRES 6 B 170 LEU GLY ASP ALA VAL LEU ASP LEU VAL VAL GLY GLU TYR SEQRES 7 B 170 LEU PHE HIS LYS PHE ALA LYS ASP ALA GLU GLY ASP LEU SEQRES 8 B 170 SER LYS LEU ARG ALA ALA LEU VAL ASN GLU LYS SER PHE SEQRES 9 B 170 ALA LYS ILE ALA ASN SER LEU ASN LEU GLY ASP PHE ILE SEQRES 10 B 170 LEU MET SER VAL ALA GLU GLU ASN ASN GLY GLY LYS GLU SEQRES 11 B 170 LYS PRO SER ILE LEU SER ASP ALA LEU GLU ALA ILE ILE SEQRES 12 B 170 GLY ALA ILE HIS LEU GLU ALA GLY PHE GLU PHE ALA LYS SEQRES 13 B 170 THR ILE ALA LEU ARG LEU ILE GLU LYS ASN PHE PRO GLN SEQRES 14 B 170 ILE SEQRES 1 C 170 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 C 170 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA MET LYS SEQRES 3 C 170 ASN ILE GLU LYS LEU GLU GLN SER LEU THR TYR GLU PHE SEQRES 4 C 170 LYS ASP LYS ASN LEU LEU ILE HIS ALA LEU THR HIS LYS SEQRES 5 C 170 SER PHE LYS LYS SER TYR ASN ASN GLU ARG LEU GLU PHE SEQRES 6 C 170 LEU GLY ASP ALA VAL LEU ASP LEU VAL VAL GLY GLU TYR SEQRES 7 C 170 LEU PHE HIS LYS PHE ALA LYS ASP ALA GLU GLY ASP LEU SEQRES 8 C 170 SER LYS LEU ARG ALA ALA LEU VAL ASN GLU LYS SER PHE SEQRES 9 C 170 ALA LYS ILE ALA ASN SER LEU ASN LEU GLY ASP PHE ILE SEQRES 10 C 170 LEU MET SER VAL ALA GLU GLU ASN ASN GLY GLY LYS GLU SEQRES 11 C 170 LYS PRO SER ILE LEU SER ASP ALA LEU GLU ALA ILE ILE SEQRES 12 C 170 GLY ALA ILE HIS LEU GLU ALA GLY PHE GLU PHE ALA LYS SEQRES 13 C 170 THR ILE ALA LEU ARG LEU ILE GLU LYS ASN PHE PRO GLN SEQRES 14 C 170 ILE SEQRES 1 D 170 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 D 170 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA MET LYS SEQRES 3 D 170 ASN ILE GLU LYS LEU GLU GLN SER LEU THR TYR GLU PHE SEQRES 4 D 170 LYS ASP LYS ASN LEU LEU ILE HIS ALA LEU THR HIS LYS SEQRES 5 D 170 SER PHE MLZ LYS SER TYR ASN ASN GLU ARG LEU GLU PHE SEQRES 6 D 170 LEU GLY ASP ALA VAL LEU ASP LEU VAL VAL GLY GLU TYR SEQRES 7 D 170 LEU PHE HIS LYS PHE ALA LYS ASP ALA GLU GLY ASP LEU SEQRES 8 D 170 SER LYS LEU ARG ALA ALA LEU VAL ASN GLU LYS SER PHE SEQRES 9 D 170 ALA LYS ILE ALA ASN SER LEU ASN LEU GLY ASP PHE ILE SEQRES 10 D 170 LEU MET SER VAL ALA GLU GLU ASN ASN GLY GLY LYS GLU SEQRES 11 D 170 LYS PRO SER ILE LEU SER ASP ALA LEU GLU ALA ILE ILE SEQRES 12 D 170 GLY ALA ILE HIS LEU GLU ALA GLY PHE GLU PHE ALA LYS SEQRES 13 D 170 THR ILE ALA LEU ARG LEU ILE GLU LYS ASN PHE PRO GLN SEQRES 14 D 170 ILE MODRES 3O2R MLZ B 31 LYS N-METHYL-LYSINE MODRES 3O2R MLZ D 31 LYS N-METHYL-LYSINE HET MLZ B 31 10 HET MLZ D 31 10 HET CL A 225 1 HET CL B 225 1 HET CL C 225 1 HET CL D 225 1 HETNAM MLZ N-METHYL-LYSINE HETNAM CL CHLORIDE ION FORMUL 2 MLZ 2(C7 H16 N2 O2) FORMUL 5 CL 4(CL 1-) FORMUL 9 HOH *973(H2 O) HELIX 1 1 ASN A 3 THR A 12 1 10 HELIX 2 2 ASP A 17 LEU A 25 1 9 HELIX 3 3 ASN A 36 PHE A 59 1 24 HELIX 4 4 ALA A 63 VAL A 75 1 13 HELIX 5 5 ASN A 76 LEU A 87 1 12 HELIX 6 6 ASN A 88 PHE A 92 5 5 HELIX 7 7 SER A 96 ASN A 102 1 7 HELIX 8 8 GLY A 103 GLU A 106 5 4 HELIX 9 9 LYS A 107 GLY A 127 1 21 HELIX 10 10 GLY A 127 PHE A 143 1 17 HELIX 11 11 ILE B 4 THR B 12 1 9 HELIX 12 12 ASP B 17 LEU B 25 1 9 HELIX 13 13 ASN B 36 PHE B 59 1 24 HELIX 14 14 ALA B 63 VAL B 75 1 13 HELIX 15 15 ASN B 76 LEU B 87 1 12 HELIX 16 16 ASN B 88 PHE B 92 5 5 HELIX 17 17 SER B 96 ASN B 102 1 7 HELIX 18 18 GLY B 103 GLU B 106 5 4 HELIX 19 19 LYS B 107 GLY B 127 1 21 HELIX 20 20 GLY B 127 PHE B 143 1 17 HELIX 21 21 ASN C 3 THR C 12 1 10 HELIX 22 22 ASP C 17 LEU C 25 1 9 HELIX 23 23 ASN C 36 PHE C 59 1 24 HELIX 24 24 ALA C 63 VAL C 75 1 13 HELIX 25 25 ASN C 76 LEU C 87 1 12 HELIX 26 26 ASN C 88 PHE C 92 5 5 HELIX 27 27 SER C 96 ASN C 102 1 7 HELIX 28 28 GLY C 103 GLU C 106 5 4 HELIX 29 29 LYS C 107 GLY C 127 1 21 HELIX 30 30 GLY C 127 PHE C 143 1 17 HELIX 31 31 ILE D 4 THR D 12 1 9 HELIX 32 32 ASP D 17 LEU D 25 1 9 HELIX 33 33 ASN D 36 PHE D 59 1 24 HELIX 34 34 ALA D 63 VAL D 75 1 13 HELIX 35 35 ASN D 76 LEU D 87 1 12 HELIX 36 36 ASN D 88 PHE D 92 5 5 HELIX 37 37 SER D 96 ASN D 102 1 7 HELIX 38 38 GLY D 103 GLU D 106 5 4 HELIX 39 39 LYS D 107 GLY D 127 1 21 HELIX 40 40 GLY D 127 PHE D 143 1 17 LINK C PHE B 30 N AMLZ B 31 1555 1555 1.33 LINK C AMLZ B 31 N LYS B 32 1555 1555 1.33 LINK C PHE D 30 N AMLZ D 31 1555 1555 1.33 LINK C AMLZ D 31 N LYS D 32 1555 1555 1.32 SITE 1 AC1 5 HIS A 23 ARG A 38 HOH A 226 HOH A 231 SITE 2 AC1 5 HOH A 823 SITE 1 AC2 4 HIS B 23 ARG B 38 HOH B 233 HOH B 408 SITE 1 AC3 4 HIS C 23 ARG C 38 HOH C 227 HOH C 298 SITE 1 AC4 4 HIS D 23 ARG D 38 HOH D 230 HOH D 376 CRYST1 38.451 61.552 118.093 90.00 90.09 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026007 0.000000 0.000041 0.00000 SCALE2 0.000000 0.016246 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008468 0.00000